CS Center

°í°´¼¾ÅÍ

> °í°´¼¾ÅÍ > ´º½º

´º½º

ÀÎü °¨¿° º¯Á¾ ¹ÙÀÌ·¯½º »ì±Õ½ÃÇè ¿¬±¸³í¹® ¹ßÇ¥(ÇÁ¶û½º ¸®¿Ë CNRS ¿¬±¸¼Ò)
ÀÛ¼ºÀÚ : °ü¸®ÀÚ( )   ÀÛ¼ºÀÏ : 2011.10.15   Á¶È¸¼ö : 1074

 º¯Á¾ ¹ÙÀÌ·¯½º »ì±Õ·Â¿¡ °üÇÑ °ø±â»ì±Õ±â¼ú ¿¬±¸³í¹® ¹ßÇ¥! 

 

 

CNRS Lyon – Laboratory for Human Virology and Pathology FRE

CNRS 3011

Since its emergence, the bird flu virus terrifies and mobilizes a large number of researchers who all try to find a solution to prevent its spread in case of human infection.

In accordance to the most optimist estimations of the World Health Organization reports, a pandemic could affect 33% of the French population and kill 0.75% of them; which is a total of 487 500 possible victims only in France. The principal vector of possible contamination identified: the air ¡¦ the air which surrounds us, the air we breathe! 

 

The BioZone technology : certified anti-bird flu!

The tests conducted under the authority of Dr. Vincent Moulès in the laboratory biosafety level 3 of the CNRS in Lyon, prove that the BioZone technology destroys the avian influenza virus H5 used in these tests, reaching up to 5.7 logs of reduction (99.9998%) in less than 0.44 seconds

Safety measures for handling this highly pathogenic virus in laboratory biosafety level 3 required the development of a specific test device as shown below.This report is available on demand and bears the reference DE084-2007 - Laboratoire de Virologie et Pathologie Humaine FRE CNRS 3011, Faculté de Médecine RTH Laennec, Lyon, France

 

 

 

 

ÀÌÀü±Û ¹ÙÀÌ¿ÀÁ¸ Á¦Ç°°ø±Þ ÆÄÆ®³Ê ±â¾÷ü ¸í´Ü!
´ÙÀ½±Û ÀÚ°¡Ç÷¾×¿ä¹ý-¿ÀÁ¸Å׶óÇÇ